Sandy Srinivas, MD, describes an experience in which a patient with renal cell carcinoma achieved a complete response following therapy with ipilimumab and nivolumab. Dr Srinivas notes that the results of the CheckMate 214 study give her hope that her patient will maintain a complete response.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Renal Cell Carcinoma: Achieving Complete Response - Medscape - Jan 31, 2022.